Significados de recurrent pregnancy loss en inglés

Case: A 36-year-old woman presented with recurrent pregnancy loss and tubal disease.

Recommended recurrent pregnancy loss screening was unnecessary in almost half the patients in our study.

Methods and materials: Women with unexplained recurrent pregnancy loss in first trimester were selected for this study.

Seven of 42 (17%) participants had abnormalities on recurrent pregnancy loss screening.

Conclusion: Thromboprophylaxis with LMWH resulted in a improved live-birth rate in patient with 2 or more consecutive unexplained recurrent pregnancy loss.

Dr. Sacha Krieg, an ob-gyn who studies recurrent pregnancy loss at the University of Kansas Medical Center in Kansas City, agreed.

The patients with unexplained recurrent pregnancy loss must be advised to go for a screening test for all this aPL antibodies.

Purpose of review: Description of genetic screening of preimplantation embryos as a means of reducing miscarriages in patients with recurrent pregnancy loss.

Recent findings: That the promise of preimplantation genetic screening (PGS) for ameliorating recurrent pregnancy loss has been fulfilled is controversial.

Recurrent pregnancy loss is a major reproductive pathology affecting 1-5% of pregnant women worldwide.